Search for: "Case v. Hatch"
Results 821 - 840
of 932
Sorted by Relevance
|
Sort by Date
26 Nov 2012, 10:19 pm
Circuit’s March 2, 2010 decision in Teva Pharms USA, Inc. v. [read post]
11 Mar 2019, 11:29 am
Orrin Hatch spoke in favor of DACA (see Kevin Johnson’s article here). [read post]
22 Aug 2012, 1:09 am
Partners, LLC v. [read post]
10 Feb 2007, 2:59 pm
Strunk v. [read post]
22 Nov 2020, 5:43 pm
The key issue in the case is whether Florida’s “120-Day Rule” (F.S. 440.20(4)) will preclude the Employer/Carrier from denying the compensability of a number of claimant’s injuries and medical conditions. [read post]
5 Jan 2008, 6:00 am
: (IP Dragon),IFPI wins the ‘illegal music download' cases against Yahoo! [read post]
23 Sep 2019, 11:27 am
The first type—an assertion of presidential communications privilege—represents the core of executive privilege that was first recognized in U.S. v. [read post]
23 Apr 2020, 4:09 pm
“Time and distance,” he emphasized, “will be the most important factors in most cases, but not necessarily every case. [read post]
14 Oct 2013, 10:42 am
In my essay, I suggest that Skinner v. [read post]
11 Jun 2018, 10:35 am
Leining v. [read post]
16 Jul 2014, 4:00 am
Actavis stressed there is no requirement to litigate Hatch Waxman to completion, and that for the past 10 years the “scope of patent” rule had worked well, with many drugs going generic. [read post]
26 Mar 2012, 1:43 am
Circuit’s 1999 decision in Pfizer Inc. v. [read post]
3 Jan 2012, 10:20 am
Ironworkers Local Union 68 v. [read post]
26 Jun 2022, 10:40 pm
" Drummond v. [read post]
27 Mar 2018, 5:00 am
The Supreme Court has acknowledged, most recently in Zivotofsky v. [read post]
14 May 2012, 7:22 am
So, we see the importance of counting our chicks only after they’ve hatched. [read post]
2 Aug 2008, 12:54 am
: (Holman’s Biotech IP Blog), Daiichi’s open offer for 20% in Ranbaxy awaits Sebi nod: (GenericsWeb), Australia/India: Strides shows thumbs up for Indian generic industry acquiring controlling interest in Ascent: (Spicy IP), Europe: Significant date ahead for EU Paediatric Regulation: (SPC Blog), India: Grave diggers, ‘immoral’ patent and the National Biotech Regulatory Authority: (Spicy IP), UK: Monster trade mark infringement case: court reveals its… [read post]
2 May 2008, 7:00 am
: Lupin v Abbott Labs: (FDA Law Blog), Plavix (Clopidogrel) – US: Apotex sues FDA to recover 180-day exclusivity on generic Plavix: (Orange Book Blog), Plavix (Clopidogrel) – US: Former Bristol-Myers Squibb executive charged over lying about Plavix deal struck with rival Apotex: (Managing Intellectual Property), Risperdal (Resperidone) – US: Apotex files motion to intervene in relisting of Risperdal patent case; Teva quickly files… [read post]
14 May 2010, 4:00 am
As with so many Hatch-Waxman 180-day exclusivity cases, it’s complicated. [read post]
26 May 2015, 8:57 am
MDEQ v. [read post]
